Science Direct – Rheumatology Letter

Modelling allopurinol-induced severe adverse cutaneous reactions

by admin
September 5, 2025

Publication date: Available online 4 September 2025 Source: The Lancet Rheumatology Author(s): Rebecca Grainger, Lisa K Stamp Read More

Science Direct

Mapping the infectious burden in VEXAS syndrome: a systematic review and rationale for prevention

by admin
September 5, 2025

Publication date: Available online 4 September 2025 Source: The Lancet Rheumatology Author(s): Valentine Ribier, Jérôme Hadjadj, Vincent… Read More

Science Direct

Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data

by admin
September 5, 2025

Publication date: Available online 4 September 2025 Source: The Lancet Rheumatology Author(s): Edoardo Cipolletta, Georgina Nakafero, Davide… Read More

Science Direct

Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial

by admin
September 5, 2025

Publication date: Available online 4 September 2025 Source: The Lancet Rheumatology Author(s): Venkatesh Krishnan, Stuart Y Keller,… Read More

Science Direct

VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms

by admin
September 5, 2025

Publication date: Available online 4 September 2025 Source: The Lancet Rheumatology Author(s): Arvind Kaul, Adam Al-Hakim, Helen… Read More

Science Direct

Biomarkers for juvenile idiopathic arthritis treatment response—have we identified them?

by admin
September 5, 2025

Publication date: Available online 4 September 2025 Source: The Lancet Rheumatology Author(s): Stephanie KA Wong, Marinka Twilt Read More

Science Direct

Effect of a treatment strategy utilising golimumab, methotrexate and corticosteroids versus methotrexate and corticosteroids in early, untreated psoriatic arthritis (GOLMePsA): a single-centre, double-blind, parallel-group, randomised controlled trial

by admin
September 4, 2025

Publication date: Available online 3 September 2025 Source: The Lancet Rheumatology Author(s): Gabriele De Marco, Elizabeth M… Read More

Science Direct

Challenges in the therapeutic management of psoriatic arthritis

by admin
September 4, 2025

Publication date: Available online 3 September 2025 Source: The Lancet Rheumatology Author(s): Dafna D Gladman Read More

Science Direct

Effectiveness of treat-to-target tapering of TNF inhibitors for psoriatic arthritis and axial spondyloarthritis in the Netherlands: 24-month follow-up of the DRESS-PS trial

by admin
August 19, 2025

Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Amy C D Peeters,… Read More

Science Direct

The imaging crisis in axial spondyloarthritis

by admin
August 19, 2025

Publication date: September 2025 Source: The Lancet Rheumatology, Volume 7, Issue 9 Author(s): Torsten Diekhoff, Denis Poddubnyy Read More